The roles of TGF-β3 and peroxynitrite in removal of hyper-radiosensitivity by priming irradiation

References

• Alvarez B, Rubbo H, Kirk M, Barnes S, Freeman BA, Radi R. 1996. Peroxynitrite-dependent tryptophan nitration. Chem Res Toxicol 9:390–396.
   PubMed Web of Science ®Google Scholar
• Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217–224.
   PubMed Web of Science ®Google Scholar
• Bergersen LH, Storm-Mathisen J, Gundersen V. 2008. Immunogold quantification of amino acids and proteins in complex subcellular compartments. Nature Protocols 3:144–152.
   PubMed Web of Science ®Google Scholar
• Booth D, Haley JD, Bruskin AM, Potten CS. 2000. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 86:53–59.
   PubMed Web of Science ®Google Scholar
• Brown PD, Wakefield LM, Levinson AD, Sporn MB. 1990. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3:35–43.
   PubMed Web of Science ®Google Scholar
• Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Investigat 105:577–587.
   PubMed Web of Science ®Google Scholar
• Edin NJ, Olsen DR, Stokke T, Pettersen EO. 2007. Recovery of low-dose hyper-radiosensitivity following a small priming dose depends on priming dose-rate. Int J Low Radiat 4:69–86.
   Google Scholar
• Edin NJ, Sandvik JA, Olsen DR, Pettersen EO. 2009a. The elimination of low-dose hyper-radiosensitivity by transfer of irradiated-cell conditioned medium depends on dose rate. Radiat Res 171:22–32.
   PubMed Web of Science ®Google Scholar
• Edin NJ, Olsen DR, Sandvik JA, Malinen E, Pettersen EO. 2012. Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation. Int J Radiat Biol 88:311–319.
   PubMed Web of Science ®Google Scholar
• Edin NJ, Olsen DR, Stokke T, Sandvik JA, Ebbesen P, Pettersen EO. 2009b. Mechanisms of the elimination of low dose hyper- radiosensitivity in T-47D cells by low dose-rate priming. Int J Radiat Biol 85:1157–1165.
   PubMed Web of Science ®Google Scholar
• Edin NJ, Sandvik JA, Vollan HS, Reger K, Gorlach A, Pettersen EO. 2013. The role of nitric oxide radicals in removal of hyper-radiosensitivity by priming irradiation. J Radiat Res 54:1015–1028.
   PubMed Web of Science ®Google Scholar
• Ehrhart EJ, Segarini P, Tsang MLS, Carroll AG, Barcellos-Hoff MH. 1997. Latent transforming growth factor β1 activation in situ: Quantitative and functional evidence after low-dose γ-irradiation. FASEB J 11:991–1002.
   PubMed Web of Science ®Google Scholar
• Gow MD, Seymour CB, Ryan LA, Mothersill CE. 2010. Induction of bystander response in human glioma cells using high-energy electrons: A role for TGF-β1. Radiat Res 173:769–778.
   PubMed Web of Science ®Google Scholar
• Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, et al. 2006. Isoform-specific activation of latent transforming growth factor β (LTGF-β) by reactive oxygen species. Radiat Res 166:839–848.
   PubMed Web of Science ®Google Scholar
• Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA, Marples B. 1996. Hypersensitivity to very-low single radiation doses: Its relationship to the adaptive response and induced radioresistance. Mutat Res 358:171–183.
   PubMed Web of Science ®Google Scholar
• Kessler J, Hahnel A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D. 2010. HIF-1alpha inhibition by siRNA or chetomin in human malignant glioma cells: Effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer 10:605.
   PubMed Web of Science ®Google Scholar
• Koumenis C, Wouters BG. 2006. ‘Translating’ tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways. Molec Cancer Res 4:423–436.
   PubMed Web of Science ®Google Scholar
• Lambin P, Marples B, Fertil B, Malaise EP, Joiner MC. 1993. Hypersensitivity of a human tumour cell line to very low radiation doses. Int J Radiat Biol 63:639–650.
   PubMed Web of Science ®Google Scholar
• MacKenzie A, Filippini S, Martin W. 1999. Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta. Br J Pharmacol 127:1159–1164.
   PubMed Web of Science ®Google Scholar
• Marples B, Joiner MC. 1993. The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population. Radiat Res 133:41–51.
   PubMed Web of Science ®Google Scholar
• Marples B, Joiner MC. 1995. The elimination of low-dose hypersensitivity in Chinese hamster V79-379A cells by pretreatment with X-rays or hydrogen peroxide. Radiat Res 141: 160–169.
   PubMed Web of Science ®Google Scholar
• Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC. 2004. Low-dose hyper-radiosensitivity: A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161:247–255.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Tomita M, Otsuka K, Hatashita M. 2009. A new paradigm in radioadaptive response developing from microbeam research. J Radiat Res (Tokyo) 50(Suppl. A):A67–79.
   Google Scholar
• Matsumoto H, Tomita M, Otsuka K, Hatashita M, Hamada N. 2011. Nitric oxide is a key molecule serving as a bridge between radiation-induced bystander and adaptive responses. Curr Mol Pharmacol 4:126–134.
   PubMedGoogle Scholar
• Pettersen EO, Larsen LH, Ramsing NB, Ebbesen P. 2005. Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors. Cell Proliferation 38:257–267.
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Bjorhovde I, Sovik A, Edin NFJ, Zachar V, Hole EO, Sandvik JA, Ebbesen P. 2007. Response of chronic hypoxic cells to low dose-rate irradiation. Int J Radiat Biol 83: 331–345.
   PubMed Web of Science ®Google Scholar
• Potten CS, Booth D, Haley JD. 1997. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 75:1454–1459.
   PubMed Web of Science ®Google Scholar
• Schaffer L, Scheid A, Spielmann P, Breymann C, Zimmermann R, Meuli M, Gassmann M, Marti HH, Wenger RH. 2003. Oxygen- regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta 24:941–950.
   PubMed Web of Science ®Google Scholar
• Shao C, Prise KM, Folkard M. 2008a. Signaling factors for irradiated glioma cells induced bystander responses in fibroblasts. Mutat Res 638:139–145.
   PubMed Web of Science ®Google Scholar
• Shao C, Folkard M, Prise KM. 2008b. Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells. Oncogene 27:434–440.
   PubMed Web of Science ®Google Scholar
• Short SC, Kelly J, Mayes CR, Woodcock M, Joiner MC. 2001. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. Int J Radiat Biol 77:655–664.
   PubMed Web of Science ®Google Scholar
• van der Vliet A, O’Neill CA, Halliwell B, Cross CE, Kaur H. 1994. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite.FEBS Lett 339:89–92.
   PubMed Web of Science ®Google Scholar
• Vodovotz Y, Chesler L, Chong H, Kim SJ, Simpson JT, DeGraff W, Cox GW, Roberts AB, Wink DA, Barcellos-Hoff MH. 1999. Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res 59:2142–2149.
   PubMed Web of Science ®Google Scholar
• Wouters BG, Skarsgard LD. 1997. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the ‘adaptive response’ and cannot be explained by a subpopulation of sensitive cells. Radiat Res 148:435–442.
   PubMed Web of Science ®Google Scholar